Loss of glyoxalase 1 induces compensatory mechanism to achieve dicarbonyl detoxification in mammalian Schwann cells.
J. Biol. Chem. 292, 3224-3238 (2016)
The glyoxalase system is a highly specific enzyme system existing in all mammalian cells which is responsible for the detoxification of dicarbonyl species, primarily methylglyoxal (MG). It has been implicated to play an essential role in preventing the increased formation of advanced glycation endproducts under certain pathological conditions. We have established the first glyoxalase 1 knock-out model (GLO1-/-) in mammalian Schwann cells using CRISPR/Cas9 technique to investigate compensatory mechanisms. Neither elevated concentrations of MG nor associated protein modifications were observed in GLO1-/- cells. Alternative detoxification of MG in GLO1-/- is achieved by increased catalytic efficiency of aldose reductase towards hemithioacetal (product of glutathione and MG), most likely caused by S-nitrosylation of aldose reductase. The hemithioacetal is mainly converted into lactaldehyde, which is paralleled by a loss of reduced glutathione. Inhibition of aldose reductase in GLO1-/- cells is associated with an increased sensitivity against MG, elevated intracellular MG levels and associated modifications, as well as increased oxidative stress. Our data suggest that aldose reductase can compensate the loss of GLO1. This might be of clinical importance within the context of neuronal diseases caused by an impaired glyoxalase system and elevated levels of dicarbonyl species, such as MG.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
cell metabolism; CRISPR/Cas; diabetes; enzyme kinetics; glycation; toxicity; aldose reductase; diabetic neuropathy; glyoxalase system; methylglyoxal; Glycation End-products; Aldose Reductase Inhibitor; Diabetic-neuropathy; Nitric-oxide; Endothelial-cells; Mass-spectrometry; Methylglyoxal; System; Complications; Proteins
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2016
Prepublished im Jahr
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
0021-9258
e-ISSN
1083-351X
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 292,
Heft: 8,
Seiten: 3224-3238
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Society for Biochemistry and Molecular Biology
Verlagsort
Bethesda
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-501900-251
Förderungen
Copyright
Erfassungsdatum
2016-12-31